QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Romanelli, F. Articles by Smith, K. M Search for Related Content PubMed PubMed Citation Articles by Romanelli, F. Articles by Smith, K. M

HIV/AIDS

Recreational Use of Sildenafil by HIV-Positive and -Negative Homosexual/Bisexual Males

Assistant Professor of Pharmacy, Clinical Specialist in HIV/AIDS, College of Pharmacy, University of Kentucky, Lexington, KY

Kelly M Smith, PharmD

Associate Professor of Pharmacy; Director, Drug Information Center, College of Pharmacy, University of Kentucky

Reprints: Frank Romanelli PharmD BCPS, College of Pharmacy, University of Kentucky, 800 Rose St., Lexington, KY 40536-0082, fax 859/323-0069, froma2{at}uky.edu

OBJECTIVE: To conduct an epidemiologic review of sildenafil in homosexual and bisexual males focusing on concurrent use with club drugs and/or antiretroviral medications.

DATA SOURCES: A search of MEDLINE was conducted (1966–September 2003), and an extensive manual review of journals was performed using the key search terms club drugs, sildenafil, antiretrovirals, and HIV.

STUDY SELECTION AND DATA EXTRACTION: All articles identified from the data sources were evaluated and information deemed relevant was included.

DATA SYNTHESIS: Several epidemiologic studies have reported that sildenafil is abused in a recreational fashion, typically with agents commonly known to be "club drugs." In this setting, sildenafil may reverse the impotence-inducing effects of the club drugs and restore sexual capabilities. Many implications of both recreational and nonrecreational use of sildenafil exist in relation to HIV disease. Concern has been raised regarding the potential effects on high-risk sexual practices. Also, several researchers have documented interactions between sildenafil and various club drugs, as well as with antiretrovirals intended for HIV disease.

CONCLUSIONS: Serious concerns exist regarding the concurrent use of sildenafil with antiretrovirals and/or club drugs. Clinicians prescribing sildenafil to patients receiving protease inhibitor–containing antiretroviral regimens should be aware of the potential for reduced sildenafil metabolism with resultant adverse effects. Additionally, untoward effects may also occur when sildenafil is used concurrently with various club drugs including amyl and butyl nitrites ("poppers").

Key Words: club drugs, HIV, sildenafil

Published Online, April 27, 2004. www.theannals.com, DOI 10.1345/aph.1D571

THIS ARTICLE IS APPROVED FOR CONTINUING EDUCATION CREDIT
ACPE UNIVERSAL PROGRAM NUMBER: 407-000-04-021-H02

This article has been cited by other articles:

				M. Holt 'Just Take Viagra': Erectile Insurance, Prophylactic Certainty and Deficit Correction in Gay Men's Accounts of Sexuopharmaceutical Use Sexualities, December 1, 2009; 12(6): 746 - 764. [Abstract] [PDF]

				D Goldmeier and D Richardson Commentary. Sex Transm Inf, September 1, 2009; 85(5): 405 - 406. [Full Text] [PDF]